hydralazine has been researched along with Infarction, Middle Cerebral Artery in 4 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Results suggest that perfusion can be augmented in ischemic stroke with norepinephrine and hydralazine." | 4.31 | Augmentation of perfusion with simultaneous vasodilator and inotropic agents in experimental acute middle cerebral artery occlusion: a pilot study. ( Carroll, T; Christoforidis, GA; Jeong, YI; Liu, M; Niekrasz, M; Roth, S; Saadat, N, 2023) |
| "Our results indicate that a combination of norepinephrine and hydralazine administered in the acute phase of ischemic stroke mitigates infarct evolution in subjects with poor but not good collateral recruitment." | 4.02 | Influence of simultaneous pressor and vasodilatory agents on the evolution of infarct growth in experimental acute middle cerebral artery occlusion. ( Ansari, SA; Carroll, T; Christoforidis, GA; Dimov, A; Jeong, YI; Liu, M; Niekrasz, M; Roth, S; Saadat, N, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M | 2 |
| Saadat, N | 2 |
| Jeong, YI | 2 |
| Roth, S | 2 |
| Niekrasz, M | 2 |
| Carroll, T | 2 |
| Christoforidis, GA | 2 |
| Dimov, A | 1 |
| Ansari, SA | 1 |
| Elewa, HF | 1 |
| Kozak, A | 1 |
| Johnson, MH | 1 |
| Ergul, A | 1 |
| Fagan, SC | 1 |
| Tejima, E | 1 |
| Katayama, Y | 1 |
| Suzuki, Y | 1 |
| Kano, T | 1 |
| Lo, EH | 1 |
4 other studies available for hydralazine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Augmentation of perfusion with simultaneous vasodilator and inotropic agents in experimental acute middle cerebral artery occlusion: a pilot study.
Topics: Animals; Brain Ischemia; Cerebrovascular Circulation; Dogs; Hydralazine; Infarction, Middle Cerebral | 2023 |
Influence of simultaneous pressor and vasodilatory agents on the evolution of infarct growth in experimental acute middle cerebral artery occlusion.
Topics: Animals; Collateral Circulation; Diffusion Magnetic Resonance Imaging; Dogs; Drug Therapy, Combinati | 2021 |
Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Are | 2007 |
Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model.
Topics: Animals; Blood Flow Velocity; Blood Gas Analysis; Blood Pressure; Brain; Cerebral Hemorrhage; Cerebr | 2001 |